{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:59:44Z","timestamp":1785265184223,"version":"3.55.0"},"reference-count":21,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Prostate cancer exhibits substantial biological heterogeneity. Although several biomarkers reflecting aggressive tumor behavior have been identified, molecular indicators related to biological adaptation to androgen deprivation remain limited. This study aimed to comparatively evaluate ISM-1 and B7-H3 expression in localized prostate cancer (LPC) and the pre-CRPC group (pre-treatment diagnostic biopsy tissue from patients who subsequently developed CRPC), and to investigate their clinicopathological associations in the pre-CRPC group. Materials and Methods: This retrospective study included 30 surgically treated LPC cases and 32 pre-CRPC cases with available prostate tissue samples obtained prior to the development of castration resistance. ISM-1 and B7-H3 expression levels were evaluated immunohistochemically using the H-score method (intensity 0\u20133 \u00d7 proportion score 0\u20133 [0%, 1\u201319%, 20\u201350%, &gt;50%]). Expression patterns were compared between LPC and pre-CRPC groups. Within the pre-CRPC group, associations with clinicopathological parameters were evaluated using H-scores as continuous variables, and time to castration resistance was analyzed using Cox regression. Results: ISM-1 expression was generally low in LPC cases, with a median H-score of 0, whereas pre-CRPC biopsy tissues demonstrated a marked increase in ISM-1 expression. B7-H3 expression was higher and more homogeneous in the pre-CRPC group compared with LPC. In the pre-CRPC group, ISM-1 and B7-H3 H-scores showed a strong positive correlation. No statistically significant associations were identified between ISM-1 or B7-H3 expression levels and most conventional clinicopathological parameters; however, both markers differed significantly across Grade Groups. Neither marker showed a statistically significant association with time to castration resistance, although ISM-1 demonstrated a non-significant trend toward a longer time to resistance. Conclusions: ISM-1 and B7-H3 exhibit distinct expression patterns across different stages of prostate cancer but show associated expression profiles in the pre-CRPC group. While B7-H3 appears to reflect aggressive tumor biology, the independent expression pattern of ISM-1 and its non-significant trend toward a longer time to resistance suggest a potential role in the clinical trajectory toward castration resistance. Combined assessment of ISM-1 and B7-H3 may contribute to a better understanding of tumor biology in patients who subsequently develop CRPC. These findings are descriptive and hypothesis-generating.<\/jats:p>","DOI":"10.3390\/medicina62030477","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:48:56Z","timestamp":1772542136000},"page":"477","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Analysis of ISM-1 and B7-H3 Expression in Castration-Resistant Prostate Adenocarcinoma: Associations with Tumor Aggressiveness and Resistance Dynamics"],"prefix":"10.3390","volume":"62","author":[{"given":"\u015eeyhmus","family":"Kaya","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-6133","authenticated-orcid":false,"given":"Abuzer","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Urology, Sivas Numune Hospital, 58140 Sivas, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-8862","authenticated-orcid":false,"given":"Ramazan O\u011fuz","family":"Y\u00fcceer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8614-271X","authenticated-orcid":false,"given":"Nisa Beg\u00fcm","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1535-7163.MCT-20-0446","article-title":"Targeting radiation-resistant prostate cancer stem cells by B7-H3 CAR T cells","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/pros.24180","article-title":"Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer","volume":"81","author":"Kildal","year":"2021","journal-title":"Prostate"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00259-024-06714-w","article-title":"Enhancing surgical outcomes: Accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging","volume":"51","author":"Tian","year":"2024","journal-title":"Eur. J. Nuclear Med. Mol. Imaging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41417-023-00644-9","article-title":"Influence of ADT on B7-H3 expression during CRPC progression from hormone-na\u00efve prostate cancer","volume":"30","author":"Kang","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2022.09.004","article-title":"B7-H3 as a therapeutic target in advanced prostate cancer","volume":"83","author":"Guo","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Y\u00fcceer, R.O., Kaya, S., Balc\u0131, S.N., E\u011filmez, H.R., Y\u0131lmaz, M., and Erd\u0131s, E. (2025). Prognostic biomarkers in isocitrate dehydrogenase wild-type glioblastoma: A focus on B7-H3. Brain Sci., 15.","DOI":"10.3390\/brainsci15020212"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114890","DOI":"10.1016\/j.biopha.2023.114890","article-title":"B7-H3 immunoregulatory roles in cancer","volume":"163","author":"Mortezaee","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.36401\/JIPO-23-18","article-title":"B7-H3 inhibitors in oncology clinical trials: A review","volume":"7","author":"Feustel","year":"2024","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hu, M., Zhang, X., Hu, C., Teng, T., and Tang, Q.-Z. (2022). A brief overview about the adipokine: Isthmin-1. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.939757"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2019161119","DOI":"10.1073\/pnas.2019161119","article-title":"ISM1 protects lung homeostasis via cell-surface GRP78-mediated alveolar macrophage apoptosis","volume":"119","author":"Lam","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e47413","DOI":"10.1097\/MD.0000000000047413","article-title":"ISM-1 expression in cutaneous mastocytosis: Diagnostic potential and comparison with CD117","volume":"105","author":"Kaya","year":"2026","journal-title":"Medicine"},{"key":"ref_12","unstructured":"Romano, J., Kromrey, J.D., Coraggio, J., and Skowronek, J. (2006, January 1\u20133). Appropriate statistics for ordinal level data: Should we really be using t-test and cohen\u2019s d for evaluating group differences on the nsse and other surveys. Proceedings of the Annual Meeting of the Florida Association of Institutional Research, Cocoa Beach, FL, USA."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1582-4934.2009.00961.x","article-title":"Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice","volume":"15","author":"Xiang","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101445","DOI":"10.1016\/j.mcp.2019.101445","article-title":"miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer","volume":"48","author":"Zheng","year":"2019","journal-title":"Mol. Cell. Probes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2019.06.007","article-title":"hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307","volume":"460","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, Y., Liang, X., Ni, J., Zhao, R., Shao, S., Lu, S., Han, W., and Yu, L. (2021). Effect of ISM1 on the immune microenvironment and epithelial\u2013mesenchymal transition in colorectal cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.681240"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1038\/s41598-019-41525-2","article-title":"RNA sequencing provides novel insights into the transcriptome of aldosterone producing adenomas","volume":"9","author":"Backman","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13148-020-00975-6","article-title":"Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer","volume":"13","author":"Suman","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102601","DOI":"10.1016\/j.tice.2024.102601","article-title":"Isthmin-1 and spexin as promising novel biomarker candidates for invasive ductal breast carcinoma","volume":"91","author":"Turk","year":"2024","journal-title":"Tissue Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"216868","DOI":"10.1016\/j.canlet.2024.216868","article-title":"Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1","volume":"590","author":"Zhou","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14423\/SMJ.0000000000000266","article-title":"Beyond PSA: Managing modern therapeutic options in metastatic castration-resistant prostate cancer","volume":"108","author":"Karzai","year":"2015","journal-title":"South. Med. J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/477\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:23:02Z","timestamp":1772547782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["medicina62030477"],"URL":"https:\/\/doi.org\/10.3390\/medicina62030477","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}